Cargando…
Renal outcomes of treatment with telmisartan in patients with stage 3–4 chronic kidney disease: A prospective, randomized, controlled trial (JINNAGA)
OBJECTIVES: Although angiotensin II receptor blockers are effective for patients with chronic kidney disease, dose-dependent renoprotective effects of angiotensin II receptor blockers in patients with moderate to severe chronic kidney disease with non-nephrotic proteinuria are not known. Our aim was...
Autores principales: | Kitamura, Mineaki, Arai, Hideyuki, Abe, Shinichi, Ota, Yuki, Muta, Kumiko, Furusu, Akira, Mukae, Hiroshi, Kohno, Shigeru, Nishino, Tomoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686635/ https://www.ncbi.nlm.nih.gov/pubmed/33282300 http://dx.doi.org/10.1177/2050312120973502 |
Ejemplares similares
-
Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis
por: Torigoe, Kenta, et al.
Publicado: (2020) -
Risk Reduction for End-Stage Renal Disease by Dietary Guidance Using the Gustatory Threshold Test for Salty Taste
por: Ota, Yuki, et al.
Publicado: (2020) -
Significance of subepithelial deposits in patients diagnosed with IgA nephropathy
por: Kitamura, Mineaki, et al.
Publicado: (2019) -
A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation
por: Oka, Satoru, et al.
Publicado: (2017) -
Improvement in Tubulointerstitial Nephritis With Glucocorticoid Therapy in an Anorexia Nervosa Patient
por: Torigoe, Kenta, et al.
Publicado: (2023)